Congenital Dyserythropoietic anemia, type 1, in a Polynesian patient:: Response to interferon α2b

被引：13

作者：

Roda, L

Pasche, J

Fournier, A

Terorotua, V

Wickramasinghe, SN

Tamary, H

Schischmanoff, PO

Tchernia, G

Delaunay, J ^{[1
]}

机构：

[1] Hop Bicetre, Serv Hematol Immunol & Cytogenet, Assistance Publ Hop Paris, Fac Med Paris Sud, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France

[2] INSERM, U 473, F-94275 Le Kremlin Bicetre, France

[3] Ctr Hosp Terr, Med Biol Lab, Papeete, France

[4] Ctr Hosp Terr, Serv Pediat, Papeete, France

[5] Ctr Hosp Terr, Serv Nephrol Hemodialyse, Papeete, France

[6] Serv Sante Publ, Tahiti, France

[7] Univ Oxford, Nuffield Dept Clin Lab Sci, London, England

[8] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England

[9] Schneiders Med Ctr Israel, Petah Tiqwa, Israel

[10] Hop Bicetre, Serv Biochim 1, Assistance Publ Hop Paris, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2002年 / 24卷 / 06期

关键词：

congenital dyserythropoietic anemia; type; 1; hemoglobin level; interferon alpha 2b; Polynesia;

D O I：

10.1097/00043426-200208000-00020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The authors attempted to assess the utility of interferon alpha2b treatment in a Polynesian girl with a relatively severe form of congenital dyserythropoietic anemia, type 1. The diagnosis was established using routine hematologic and biochemical tests, light and electron microscopy, and electrophoresis of red cell membrane proteins. Response to the treatment was monitored using the blood count and reticulocyte count.

引用

页码：503 / 506

页数：4

共 24 条

[11] MAEDA K, 1980, AM J CLIN PATHOL, V73, P433
[12] Menike D, 1998, BRIT J HAEMATOL, V103, P825
[13] Severe congenital dyserythropoietic anaemia type I:: prenatal management, transfusion support and alpha-interferon therapy
Parez, N
Dommergues, M
Zupan, V
Chambost, ZH
Fieschi, JB
Delaunay, J
Miélot, F
Cramer, EM
Dommergues, JP
Wickramasinghe, SN
Tchernia, G
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (02) : 420 - 423
[14] Diagnosis and clinical course of congenital dyserythropoietic anaemia type 1 in a 12-year-old girl
Rössler, J
Heimpel, H
Havers, W
[J]. EUROPEAN JOURNAL OF PEDIATRICS, 2001, 160 (02) : 139 - 140
[15] Neonatal manifestations of congenital dyserythropoietic anemia type I
Shalev, H
Tamary, H
Shaft, D
Reznitsky, P
Zaizov, R
[J]. JOURNAL OF PEDIATRICS, 1997, 131 (01) : 95 - 97
[16] Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension of the newborn
Shalev, H
Moser, A
Kapelushnik, J
Karplus, M
Zucker, N
Yaniv, I
Tamary, H
[J]. JOURNAL OF PEDIATRICS, 2000, 136 (04) : 553 - 555
[17] Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I
Shamseddine, A
Taher, A
Jaafar, H
Haidar, JH
Nasr, R
Arzoumanian, V
Salem, Z
Bazarbachi, A
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (03) : 207 - 209
[18] Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3
Tamary, H
Shalmon, L
Shalev, H
Halil, A
Dobrushin, D
Ashkenazi, N
Zoldan, M
Resnitzky, P
Korostishevsky, M
Bonne-Tamir, B
Zaizov, R
[J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) : 1062 - 1069
[19] Tamary H, 1996, BLOOD, V87, P1763
[20] No response to recombinant human erythropoietin therapy in patients with congenital dyserythropoietic anemia type I
Tamary, H
Shalev, H
Pinsk, V
Zoldan, M
Zaizov, R
[J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (02) : 165 - 168

← 1 2 3 →